Henry Meds vs Hers
Hers has an open FDA warning letter dated September 9, 2025. Henry Meds has none. On compounded semaglutide injection, Hers costs $1,176 less a year at standing rates: $199 a month against $297 a month at Henry Meds.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
Henry Meds / Hers
Henry Meds
5.6/10
Hers
6.8/10
- Apostrophe Pharmacy LLCtype not stated
- XeCare LLCtype not stated
- MedisourceRx503B
Neither Henry Meds nor Hers pays us. Links to them earn nothing. Scores: Henry Meds 5.6, Hers 6.8. How we are paid
What the record shows
- 01
Hers has an open FDA warning letter dated September 9, 2025. Henry Meds has none.
- 02
Hers names three pharmacies. Henry Meds names no compounding pharmacy in our record.
- 03
On compounded semaglutide injection, Hers costs $1,176 less a year at standing rates: $199 a month against $297 a month at Henry Meds.
- 04
Only Henry Meds lists a price for compounded tirzepatide injection and compounded oral semaglutide. Only Hers lists a price for brand-name tirzepatide pen.
- 05
Hers lists all 50 states. Henry Meds publishes no state list.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Henry Meds
Hers
$297/mo
$3,564 a year
$199/moLower
$2,388 a year
$349/mo
$4,188 a year
$299/mo
medication only, membership extra; not compared
$249/mo
$2,988 a year
Read off each seller’s own pages. Henry Meds: October 30, 2026. Hers: September 28, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Henry Meds
5.6/10- No FDA warning letter on record
- Sells compounded tirzepatide injection and compounded oral semaglutide, which Hers does not price
- Price includes clinician visits
- Names no compounding pharmacy
- Publishes no state list
The case for Hers
6.8/10- $1,176 a year less on compounded semaglutide injection
- Sells brand-name tirzepatide pen, which Henry Meds does not price
- Names its compounding pharmacy
- Open FDA warning letter, September 9, 2025
- Price leaves out clinician visits and coaching
Scores
Henry Meds 5.6 · Hers 6.8 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Henry Meds vs Hers: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- HealthRX8.2
From $165/mo
Visit site - YourEra9.0
From $99/mo
Visit site - Collective9.1
From $59/mo
Visit site
Sellers closest to these two
- Henry Meds vs Direct Meds
- Henry Meds vs Fridays
- Henry Meds vs Zealthy
- Henry Meds vs TrimRx
- Hers vs Noom
- Hers vs Gala
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks